175 related articles for article (PubMed ID: 12665806)
21. Data from human research projects will now be available to public.
Maloney DM
Hum Res Rep; 2001 Apr; 16(4):1-2. PubMed ID: 11883453
[No Abstract] [Full Text] [Related]
22. RNA interference: a critical analysis of the regulatory and ethical issues encountered in the development of a novel therapy.
McKnight R
Albany Law J Sci Technol; 2004; 15(1):73-108. PubMed ID: 17340758
[No Abstract] [Full Text] [Related]
23. Inquiry into gene therapy widens.
Grisham J
Nat Biotechnol; 2000 Mar; 18(3):254-5. PubMed ID: 10700127
[No Abstract] [Full Text] [Related]
24. Gene therapy. Panel reviews risks of germ line changes.
Marshall E
Science; 2001 Dec; 294(5550):2268-9. PubMed ID: 11743173
[No Abstract] [Full Text] [Related]
25. FDA halts 27 gene therapy trials after illness: leukemia-like cases in 2 children in France prompt the action.
Pollack A
N Y Times Web; 2003 Jan; ():A1, A17. PubMed ID: 12647754
[No Abstract] [Full Text] [Related]
26. FDA to weigh test of blood substitute out of public view.
Burton T
Wall St J (East Ed); 2006 Jul; ():D3. PubMed ID: 16906688
[No Abstract] [Full Text] [Related]
27. Public have right to see data from all gene trials, says FDA.
Smaglik P
Nature; 2001 Jan; 409(6819):442. PubMed ID: 11206508
[No Abstract] [Full Text] [Related]
28. Gene therapy. What to do when clear success comes with an unclear risk?
Marshall E
Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
[No Abstract] [Full Text] [Related]
29. US plans to protect clinical research participants.
Fox JL
Nat Biotechnol; 2000 Jul; 18(7):709. PubMed ID: 10888829
[No Abstract] [Full Text] [Related]
30. The limiting factor. Biotechnology and the charter for an international science and technology reference court.
Zweig FM
Not Polit; 2002; 18(65):51-8. PubMed ID: 15505917
[No Abstract] [Full Text] [Related]
31. Gene therapy. Second child in French trial is found to have leukemia.
Marshall E
Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
[No Abstract] [Full Text] [Related]
32. Gene therapy. Panel urges limits on X-SCID trials.
Kaiser J
Science; 2005 Mar; 307(5715):1544-5. PubMed ID: 15761128
[No Abstract] [Full Text] [Related]
33. More flexibility on reporting to federal agencies about injuries to research subjects.
Maloney DM
Hum Res Rep; 2002 Jan; 17(1):1-2. PubMed ID: 16270435
[No Abstract] [Full Text] [Related]
34. Gene therapy is facing a crucial hearing.
Harris G
N Y Times Web; 2005 Mar; ():A16. PubMed ID: 15940856
[No Abstract] [Full Text] [Related]
35. Fifteen-year follow up for gene therapy patients.
Birmingham K
Nat Med; 2001 Dec; 7(12):1263. PubMed ID: 11726945
[No Abstract] [Full Text] [Related]
36. Children as research subjects: guinea pigs or therapeutic orphans?
Tauer C
Bioeth Exam; 2003; 7(2):1-2, 4-5. PubMed ID: 15025108
[No Abstract] [Full Text] [Related]
37. Trials are halted on gene therapy: child in experiment falls ill--new setback for research.
Stolberg SG
N Y Times Web; 2002 Oct; ():A1, A25. PubMed ID: 12474837
[No Abstract] [Full Text] [Related]
38. FDA penalizes trial misconduct.
Shaffer C
Nat Biotechnol; 2009 Oct; 27(10):872. PubMed ID: 19816424
[No Abstract] [Full Text] [Related]
39. Investigation of gene therapy begins.
Fox JL
Nat Biotechnol; 2000 Feb; 18(2):143-4. PubMed ID: 10657112
[No Abstract] [Full Text] [Related]
40. US company's gene therapy trial is first to bypass RAC for approval.
Anderson C
Nature; 1992 Jun; 357(6380):615. PubMed ID: 1614498
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
